Bioventix (BVXP)

London
3,377.0
+27.0(+0.81%)
  • Volume:
    76
  • Bid/Ask:
    3,300.0/3,400.0
  • Day's Range:
    3,377.0 - 3,377.0
Earnings results expected in 14 days

Bioventix will announce its quarterly financial results in days. Traders should take this into account as the share price often fluctuates around this time period.

1 / 2

BVXP Overview

Prev. Close
3,350
Day's Range
3,377-3,377
Revenue
10.5M
Open
3,350
52 wk Range
2,880-4,000
EPS
1.26
Volume
76
Market Cap
175.92M
Dividend (Yield)
152.00
(4.54%)
Average Volume (3m)
8,774
P/E Ratio
25.37
Beta
0.27
1-Year Change
-15.72%
Shares Outstanding
5,209,333
Next Earnings Date
16 Oct 2022
What is your sentiment on Bioventix?
or
Vote to see community's results!

Bioventix News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Bioventix Analysis

Bioventix Company Profile

Bioventix Company Profile

Employees
12

Bioventix PLC is a United Kingdom-based biotechnology company. The principal activity of the Company is the development and supply of antibodies. The Company specializes in the development of sheep monoclonal antibodies (SMAs) for use in immunodiagnostics focusing on the areas of clinical diagnostics, such as in automated immunoassays used in blood testing. The Company offers a portfolio of antibodies to customers for both commercial use and research and development (R&D) purposes, for the diagnosis or monitoring of a range of conditions, including heart disease, cancer, fertility, thyroid function and drug abuse. The Company also supplies antibody products and services to multinational clinical diagnostics companies. The Company sells its products through direct sales and through distributors.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyNeutral